← Browse by Condition
Medical Condition
colo rectal cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT07085169 Phase 2
Recruiting
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Enrollment
50 pts
Location
China
Sponsor
Ruijin Hospital
NCT07003022 Phase 2
Recruiting
Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
Enrollment
40 pts
Location
China
Sponsor
Fudan University
NCT07046585
Recruiting
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
Enrollment
25,000 pts
Location
United States
Sponsor
Natera, Inc.